Table 2.
Subjective global symptom assessment n (%)
Better | Same | Worse | Total | |
Group A | 20 (71.4) | 7 (25.0) | 1 (3.6) | 28 |
Group B | 17 (65.4) | 8 (30.8) | 1 (3.8) | 26 |
Total | 37 | 15 | 2 | 54 |
P = 0.9; Group A, rabeprazole; Group B, ranitidine.
Subjective global symptom assessment n (%)
Better | Same | Worse | Total | |
Group A | 20 (71.4) | 7 (25.0) | 1 (3.6) | 28 |
Group B | 17 (65.4) | 8 (30.8) | 1 (3.8) | 26 |
Total | 37 | 15 | 2 | 54 |
P = 0.9; Group A, rabeprazole; Group B, ranitidine.